bpc-157 human clinical evidence review safety fda warning trial and the Difference Between an Gap FDA's Overreach on Compounded Peptides

FDA's Overreach on Compounded Peptides FDA advisers back first four of seven unapproved peptides under review for looser rules The Mighty 790 KFGO KFGO Federal health advisers are meeting to review a group of controversial chemicals called peptides, which have become a growing wellness trend. FULL STORY Health advisers begin meeting Thursday to review more than a half dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective. Full story If BPC 157 worked as well as the internet says it does, wed probably have high quality human trials by now., Instead we have, Lots of rat studies., Lots of podcasts., Lots of gym bros and Most FDA advisers say peptides like BPC 157 and TB 500 should be made available in the U.S. Here's what happens next. MarketWatch

SKU: 32910677537 · From southroadsurgery.com.au